INSERM, U744, Lille, France.
Neurobiol Aging. 2011 Apr;32(4):624-30. doi: 10.1016/j.neurobiolaging.2009.04.007. Epub 2009 May 7.
Because the action of thyroid hormone (T3) is involved in adult cognitive functions, we wanted to assess the association between THRA gene polymorphisms, which encodes the T3 nuclear receptor TRα1, and Alzheimer's disease (AD) risk. We analysed 5 single nucleotide polymorphisms (SNPs) of THRA, covering the known common genetic variability of the gene, in the Lille AD case-control study (710 cases/597 controls). We observed that subjects bearing the rs939348 TT genotype had a tendency to have a higher risk of developing AD (adjusted OR [95%CI]=1.71 [0.99-2.95] p=0.06). We extended our finding to three other independent AD case-control studies and observed similar trends. When combining the 4 studies (1749 cases/1339 controls), we observed an overall significant higher risk of AD in TT subjects (adjusted OR [95%CI]=1.42 [1.03-1.96], p=0.03) compared with C allele bearers. However, when combining our data with the available data coming from 2 American genome wide association studies on AD, we observed a weak and not significant association (OR=1.19 [0.97-1.45], p=0.10). The relationship between the genetic variability of the THRA gene and AD risk remains uncertain but cannot be entirely excluded.
由于甲状腺激素(T3)的作用涉及到成人的认知功能,我们希望评估编码 T3 核受体 TRα1 的 THRA 基因多态性与阿尔茨海默病(AD)风险之间的关联。我们在里尔 AD 病例对照研究(710 例病例/597 例对照)中分析了 THRA 的 5 个单核苷酸多态性(SNP),涵盖了该基因已知的常见遗传变异性。我们观察到,携带 rs939348 TT 基因型的受试者有发展 AD 的更高风险(调整后的 OR [95%CI] = 1.71 [0.99-2.95],p = 0.06)。我们将我们的发现扩展到另外三个独立的 AD 病例对照研究中,并观察到类似的趋势。当合并这 4 项研究(1749 例病例/1339 例对照)时,我们观察到 TT 受试者发生 AD 的总体风险显著升高(调整后的 OR [95%CI] = 1.42 [1.03-1.96],p = 0.03),与 C 等位基因携带者相比。然而,当将我们的数据与来自 AD 的 2 项美国全基因组关联研究的可用数据合并时,我们观察到一个微弱且无统计学意义的关联(OR = 1.19 [0.97-1.45],p = 0.10)。THRA 基因的遗传多态性与 AD 风险之间的关系仍不确定,但不能完全排除。